Safety, Immunogenicity, and Efficacy of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine in Women Aged 24–45 years: A Randomized, Double-blind Trial
Corson, Stephen L.Volume:
16
Year:
2009
Language:
english
DOI:
10.1016/j.jmig.2009.06.010
File:
PDF, 45 KB
english, 2009